TNF Pharmaceuticals, Inc. Long-term Investment Intensity
TNF Pharmaceuticals, Inc. long-term investment intensity. TNF Pharmaceuticals, Inc. (TNFA) has a Long-term Investment Intensity of 8.7% as of June 2025. Long-term investments of $1.50 Million represent 8.7% of total assets of $17.15 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read TNF Pharmaceuticals, Inc. (TNFA) financial obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of TNF Pharmaceuticals, Inc. (2021–2024)
Long-term investment intensity of TNF Pharmaceuticals, Inc. from 2021 to 2024. This chart shows how TNF Pharmaceuticals, Inc.'s Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the intensity stands at 8.7%, reflecting long-term investments of $1.50 Million against total assets of $17.15 Million USD.
TNF Pharmaceuticals, Inc. Long-term Investment Intensity by Year (2021–2024)
TNF Pharmaceuticals, Inc. long-term investment intensity by year from 2021 to 2024. The table below presents the year-by-year Long-term Investment Intensity for TNF Pharmaceuticals, Inc. from 2021 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see TNFA total asset value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 7.0% | $1.50 Million | $21.42 Million | ▼ -1.4 pp |
| 2023 | 8.4% | $1.50 Million | $17.86 Million | ▼ -0.2 pp |
| 2022 | 8.6% | $1.50 Million | $17.54 Million | ▲ +2.5 pp |
| 2021 | 6.0% | $1.50 Million | $24.81 Million | — |